1-5 of 5
Filippa Pettersson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Acquired Resistance to EZH2 Inhibitor GSK343 Promotes the Differentiation of Human DLBCL Cell Lines toward an ABC-Like Phenotype

Available to Purchase
Samuel E.J. Preston, Audrey Emond, Filippa Pettersson, Daphné Dupéré-Richer, Madelyn Jean Abraham, Alberto Riva, Mena Kinal, Ryan N. Rys, Nathalie A. Johnson, Koren K. Mann, Sonia V. del Rincón, Jonathan D. Licht, Wilson H. Miller, Jr
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (4): 511–521.
https://doi.org/10.1158/1535-7163.MCT-21-0216
Published: 01 April 2022
View articletitled, Acquired Resistance to EZH2 Inhibitor GSK343 Promotes the Differentiation of Human DLBCL Cell Lines toward an ABC-Like Phenotype
Open the PDF for Acquired Resistance to EZH2 Inhibitor GSK343 Promotes the Differentiation of Human DLBCL Cell Lines toward an ABC-Like Phenotype in another window
Includes: Supplementary data
Journal Articles

Abstract A154: Inhibition of eIF4E with Ribavirin suppresses EMT and breast cancer invasiveness.

Free
Audrey Emond, Sonia V. Del Rincon, Bonnie Huor, Filippa Pettersson, Wilson H. Miller
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A154.
https://doi.org/10.1158/1535-7163.TARG-13-A154
Published: 01 November 2013
View articletitled, Abstract A154: Inhibition of eIF4E with Ribavirin suppresses EMT and breast cancer invasiveness.
Journal Articles

Expression of Leukemia-Associated Fusion Proteins Increases Sensitivity to Histone Deacetylase Inhibitor–Induced DNA Damage and Apoptosis

Free
Luca A. Petruccelli, Filippa Pettersson, Sonia V. del Rincón, Cynthia Guilbert, Jonathan D. Licht, Wilson H. Miller, Jr
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (8): 1591–1604.
https://doi.org/10.1158/1535-7163.MCT-12-1039
Published: 08 August 2013
View articletitled, Expression of Leukemia-Associated Fusion Proteins Increases Sensitivity to Histone Deacetylase Inhibitor–Induced DNA Damage and Apoptosis
Open the PDF for Expression of Leukemia-Associated Fusion Proteins Increases Sensitivity to Histone Deacetylase Inhibitor–Induced DNA Damage and Apoptosis in another window
Includes: Supplementary data
Journal Articles

Abstract A189: Expression of fusion proteins in acute myeloid leukemia cells increases sensitivity to histone deacetylase inhibitors

Free
Luca A. Petruccelli, Filippa Pettersson, Daphne Dupere‐Richer, Kim L. Rice, Jonathan D. Licht, Wilson H. Miller, Jr.
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): A189.
https://doi.org/10.1158/1535-7163.TARG-09-A189
Published: 10 December 2009
View articletitled, Abstract A189: Expression of fusion proteins in acute myeloid leukemia cells increases sensitivity to histone deacetylase inhibitors
Journal Articles

Abstract A188: Proapoptotic versus prosurvival function of the MAP kinase p38 induced by HDAC inhibitor in hematological malignant cells

Free
Daphné Dupéré‐Richer, Luca Petruccelli, Hélène Retrouvey, Monica Dobocan, Miranda Tomenson, Filippa Pettersson, Wilson H. Miller, Jr.
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): A188.
https://doi.org/10.1158/1535-7163.TARG-09-A188
Published: 10 December 2009
View articletitled, Abstract A188: Proapoptotic versus prosurvival function of the MAP kinase p38 induced by HDAC inhibitor in hematological malignant cells